메뉴 건너뛰기




Volumn 22, Issue 4, 2010, Pages 330-335

Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: Current status and recent developments

Author keywords

adjuvant; GIST; imatinib; neoadjuvant

Indexed keywords

IMATINIB; PLACEBO;

EID: 77953960843     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32833aaaad     Document Type: Review
Times cited : (22)

References (39)
  • 2
    • 0642368571 scopus 로고    scopus 로고
    • Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
    • Heinrich MC, Corless CL, Demetri GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003; 21:4342-4349.
    • (2003) J Clin Oncol , vol.21 , pp. 4342-4349
    • Heinrich, M.C.1    Corless, C.L.2    Demetri, G.D.3
  • 3
    • 0344667592 scopus 로고    scopus 로고
    • A two-arm phase II study of temozo-lomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas
    • Trent JC, Beach J, Burgess MA, et al. A two-arm phase II study of temozo-lomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. Cancer 2003; 98:2693-2699.
    • (2003) Cancer , vol.98 , pp. 2693-2699
    • Trent, J.C.1    Beach, J.2    Burgess, M.A.3
  • 4
    • 20844433223 scopus 로고    scopus 로고
    • Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomised trial
    • Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 2004; 364:1127-1134.
    • (2004) Lancet , vol.364 , pp. 1127-1134
    • Verweij, J.1    Casali, P.G.2    Zalcberg, J.3
  • 5
    • 0035810148 scopus 로고    scopus 로고
    • Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
    • Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344:1052-1056.
    • (2001) N Engl J Med , vol.344 , pp. 1052-1056
    • Joensuu, H.1    Roberts, P.J.2    Sarlomo-Rikala, M.3
  • 6
    • 0036769721 scopus 로고    scopus 로고
    • Update of phase i study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: A report of the EORTC Soft Tissue and Bone Sarcoma Group
    • van Oosterom AT, Judson IR, Verweij J, et al. Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2002; 38 (Suppl 5):S83-S87.
    • (2002) Eur J Cancer , vol.38 , Issue.SUPPL. 5
    • Van Oosterom, A.T.1    Judson, I.R.2    Verweij, J.3
  • 7
    • 39149127634 scopus 로고    scopus 로고
    • Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033
    • BlankeCD, Rankin C, Demetri GD, et al. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 2008; 26:626-632.
    • (2008) J Clin Oncol , vol.26 , pp. 626-632
    • Blankecd Rankin, C.1    Demetri, G.D.2
  • 9
    • 0033984319 scopus 로고    scopus 로고
    • Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival
    • DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231:51-58.
    • (2000) Ann Surg , vol.231 , pp. 51-58
    • Dematteo, R.P.1    Lewis, J.J.2    Leung, D.3
  • 10
    • 62849096370 scopus 로고    scopus 로고
    • Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: A rando mised, double-blind, placebo-controlled trial
    • Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a rando mised, double-blind, placebo-controlled trial. Lancet 2009; 373:1097-1104.
    • (2009) Lancet , vol.373 , pp. 1097-1104
    • Dematteo, R.P.1    Ballman, K.V.2    Antonescu, C.R.3
  • 11
    • 77953958051 scopus 로고    scopus 로고
    • Efficacy of adjuvant imatinib mesylate following complete resection of localized primary gastrointestinal stromal tumor (GIST) at high risk of recurrence: the U.S. Intergroup phase II trial ACOSOG Z9000 [abstract]
    • DeMatteo RP, Owzar K, Antonescu CR, et al. Efficacy of adjuvant imatinib mesylate following complete resection of localized, primary gastrointestinal stromal tumor (GIST) at high risk of recurrence: the U.S. Intergroup phase II trial ACOSOG Z9000 [abstract]. American Society of Clinical Oncology (ASCO) 2008 Gastrointestinal Cancers Symposium; 2008.
    • (2008) American Society of Clinical Oncology (ASCO) 2008 Gastrointestinal Cancers Symposium
    • Dematteo, R.P.1    Owzar, K.2    Antonescu, C.R.3
  • 12
    • 23844507560 scopus 로고    scopus 로고
    • Adjuvant imatinib mesylate in pa tients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: Safety results from the U.S. Intergroup Phase II trial ACOSOG Z9000
    • American College of Surgeons Oncology Group (ACOSOG)
    • DeMatteo RP, Antonescu CR, Chadaram V, et al., American College of Surgeons Oncology Group (ACOSOG). Adjuvant imatinib mesylate in pa tients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: safety results from the U.S. Intergroup Phase II trial ACOSOG Z9000. J Clin Oncol 2005; 23 (16 Suppl):9009.
    • (2005) J Clin Oncol , vol.23 , Issue.16 SUPPL. , pp. 9009
    • Dematteo, R.P.1    Antonescu, C.R.2    Chadaram, V.3
  • 13
    • 77952503219 scopus 로고    scopus 로고
    • A phase II study of imatinib mesylate as adjuvant treatment for curatively resected high-risk localized gastrointestinal stromal tumors
    • [abstract #e21515]
    • Kang B, Lee J, Ryu M, et al. A phase II study of imatinib mesylate as adjuvant treatment for curatively resected high-risk localized gastrointestinal stromal tumors [abstract #e21515]. J Clin Oncol 2009; 27 (Suppl).
    • (2009) J Clin Oncol , vol.27 , Issue.SUPPL.
    • Kang, B.1    Lee, J.2    Ryu, M.3
  • 14
    • 62149141753 scopus 로고    scopus 로고
    • A randomized, phase II study of preoperative plus postoperative imatinib in GIST: Evidence of rapid radio graphic response and temporal induction of tumor cell apoptosis
    • McAuliffe JC, Hunt KK, Lazar AJ, et al. A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radio graphic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 2009; 16:910-919.
    • (2009) Ann Surg Oncol , vol.16 , pp. 910-919
    • McAuliffe, J.C.1    Hunt, K.K.2    Lazar, A.J.3
  • 15
    • 58149399145 scopus 로고    scopus 로고
    • Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent oper able gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665
    • Eisenberg BL, Harris J, BlankeCD, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent oper able gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol 2009; 99:42-47.
    • (2009) J Surg Oncol , vol.99 , pp. 42-47
    • Eisenberg, B.L.1    Harris, J.2    Blankecd3
  • 16
    • 33749263716 scopus 로고    scopus 로고
    • Perforated GIST of the small intestine as a rare cause of acute abdomen: Surgical treatment and adjuvant therapy. Case report
    • Efremidou EI, Liratzopoulos N, Papageorgiou MS, et al. Perforated GIST of the small intestine as a rare cause of acute abdomen: surgical treatment and adjuvant therapy. Case report. J Gastrointestin Liver Dis 2006; 15:297-299.
    • (2006) J Gastrointestin Liver Dis , vol.15 , pp. 297-299
    • Efremidou, E.I.1    Liratzopoulos, N.2    Papageorgiou, M.S.3
  • 17
    • 34547493419 scopus 로고    scopus 로고
    • Primary omental gastrointestinal stromal tumor (GIST)
    • Todoroki T, Sano T, Sakurai S, et al. Primary omental gastrointestinal stromal tumor (GIST). World J Surg Oncol 2007; 5:66.
    • (2007) World J Surg Oncol , vol.5 , pp. 66
    • Todoroki, T.1    Sano, T.2    Sakurai, S.3
  • 18
    • 44949165555 scopus 로고    scopus 로고
    • A malignant omental extra-gastrointestinal stromal tumor on a young man: A case report and review of the literature
    • Castillo-Sang M, Mancho S, Tsang AW, et al. A malignant omental extra-gastrointestinal stromal tumor on a young man: a case report and review of the literature. World J Surg Oncol 2008; 6:50.
    • (2008) World J Surg Oncol , vol.6 , pp. 50
    • Castillo-Sang, M.1    Mancho, S.2    Tsang, A.W.3
  • 19
    • 0042978501 scopus 로고    scopus 로고
    • Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A centre-based study of 17 patients
    • Bumming P, Andersson J, Meis-Kindblom JM, et al. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer 2003; 89:460-464.
    • (2003) Br J Cancer , vol.89 , pp. 460-464
    • Bumming, P.1    Andersson, J.2    Meis-Kindblom, J.M.3
  • 20
    • 34249791491 scopus 로고    scopus 로고
    • Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)
    • Nilsson B, Sjolund K, Kindblom LG, et al. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST). Br J Cancer 2007; 96:1656-1658.
    • (2007) Br J Cancer , vol.96 , pp. 1656-1658
    • Nilsson, B.1    Sjolund, K.2    Kindblom, L.G.3
  • 21
    • 32944465148 scopus 로고    scopus 로고
    • A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively
    • Okuda H, Tanaka H, Ueno M, et al. A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively. Gan To Kagaku Ryoho 2005; 32:1941-1944.
    • (2005) Gan to Kagaku Ryoho , vol.32 , pp. 1941-1944
    • Okuda, H.1    Tanaka, H.2    Ueno, M.3
  • 22
    • 67649130820 scopus 로고    scopus 로고
    • Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: A case report
    • Ciresa M, D'Angelillo RM, Ramella S, et al. Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report. Tumori 2009; 95:236-239.
    • (2009) Tumori , vol.95 , pp. 236-239
    • Ciresa, M.1    D'Angelillo, R.M.2    Ramella, S.3
  • 23
    • 67651253137 scopus 로고    scopus 로고
    • Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor
    • Hou YY, Zhou Y, Lu SH, et al. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor. World J Gastroenterol 2009; 15:1910-1913.
    • (2009) World J Gastroenterol , vol.15 , pp. 1910-1913
    • Hou, Y.Y.1    Zhou, Y.2    Lu, S.H.3
  • 24
    • 79959798391 scopus 로고    scopus 로고
    • Successful resection of an advanced gastrointestinal stromal tumor by neoadjuvant chemotherapy with imatinib: A case report
    • Nakajima S, Sonoda K, Kadokawa Y, et al. Successful resection of an advanced gastrointestinal stromal tumor by neoadjuvant chemotherapy with imatinib: a case report. Gan To Kagaku Ryoho 2009; 36:2645-2648.
    • (2009) Gan to Kagaku Ryoho , vol.36 , pp. 2645-2648
    • Nakajima, S.1    Sonoda, K.2    Kadokawa, Y.3
  • 25
    • 33845633389 scopus 로고    scopus 로고
    • Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
    • Andtbacka RH, Ng CS, Scaife CL, et al. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 2007; 14:14-24.
    • (2007) Ann Surg Oncol , vol.14 , pp. 14-24
    • Andtbacka, R.H.1    Ng, C.S.2    Scaife, C.L.3
  • 26
    • 34247610583 scopus 로고    scopus 로고
    • Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor
    • DeMatteo RP, Maki RG, Singer S, et al. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 2007; 245:347-352.
    • (2007) Ann Surg , vol.245 , pp. 347-352
    • Dematteo, R.P.1    Maki, R.G.2    Singer, S.3
  • 27
    • 77951810587 scopus 로고    scopus 로고
    • Neoadjuvant imatinib and organ preservation in locally advanced gastrointestinal stromal tumors (GIST)
    • [abstract #10550]
    • Hohenberger P, Oladeji O, Licht T, et al. Neoadjuvant imatinib and organ preservation in locally advanced gastrointestinal stromal tumors (GIST) [abstract #10550]. J Clin Oncol 2009; 27 (15 Suppl).
    • (2009) J Clin Oncol , vol.27 , Issue.15 SUPPL.
    • Hohenberger, P.1    Oladeji, O.2    Licht, T.3
  • 28
    • 76649092813 scopus 로고    scopus 로고
    • Neoadjuvant imatinib in patients with locally advanced GIST in the prospective BFR14 trial
    • [abstract #10551]
    • Cassier PA, Blesius AA, Perol D, et al. Neoadjuvant imatinib in patients with locally advanced GIST in the prospective BFR14 trial [abstract #10551]. J Clin Oncol 2009; 27 (15 Suppl).
    • (2009) J Clin Oncol , vol.27 , Issue.15 SUPPL.
    • Cassier, P.A.1    Blesius, A.A.2    Perol, D.3
  • 29
    • 68849122493 scopus 로고    scopus 로고
    • Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor
    • Rink L, Skorobogatko Y, Kossenkov AV, et al. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Mol Cancer Ther 2009; 8:2172-2182.
    • (2009) Mol Cancer Ther , vol.8 , pp. 2172-2182
    • Rink, L.1    Skorobogatko, Y.2    Kossenkov, A.V.3
  • 30
    • 33750076675 scopus 로고    scopus 로고
    • Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor
    • Trent JC, Ramdas L, Dupart J, et al. Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor. Cancer 2006; 107:1898-1908.
    • (2006) Cancer , vol.107 , pp. 1898-1908
    • Trent, J.C.1    Ramdas, L.2    Dupart, J.3
  • 31
    • 36749006701 scopus 로고    scopus 로고
    • Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate
    • McAuliffe JC, Lazar AJ, Yang D, et al. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res 2007; 13 (22 Pt 1):6727-6734.
    • (2007) Clin Cancer Res , vol.13 , Issue.22 PART 1 , pp. 6727-6734
    • McAuliffe, J.C.1    Lazar, A.J.2    Yang, D.3
  • 32
    • 34447557780 scopus 로고    scopus 로고
    • NCCN Task Force report: Management of patients with gastrointestinal stromal tumor (GIST): Update of the NCCN clinical practice guidelines
    • quiz S30
    • Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST): update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2007; 5 (Suppl 2):S1-S29; quiz S30.
    • (2007) J Natl Compr Canc Netw , vol.5 , Issue.SUPPL. 2
    • Demetri, G.D.1    Benjamin, R.S.2    Blanke, C.D.3
  • 33
    • 43049167312 scopus 로고    scopus 로고
    • Imatinib mesilate for the treatment of gastrointestinal stromal tumour
    • Cassier PA, Dufresne A, Arifi S, et al. Imatinib mesilate for the treatment of gastrointestinal stromal tumour. Expert Opin Pharmacother 2008; 9:1211-1222.
    • (2008) Expert Opin Pharmacother , vol.9 , pp. 1211-1222
    • Cassier, P.A.1    Dufresne, A.2    Arifi, S.3
  • 34
    • 61449120255 scopus 로고    scopus 로고
    • Controversies in the surgical management of GIST in the era of imatinib
    • Raut CP, Bertagnolli MM. Controversies in the surgical management of GIST in the era of imatinib. Oncology (Williston Park) 2009; 23:69; 74-76.
    • (2009) Oncology (Williston Park) , vol.23-69 , pp. 74-76
    • Raut, C.P.1    Bertagnolli, M.M.2
  • 35
    • 62849115588 scopus 로고    scopus 로고
    • Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group
    • the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)
    • Gronchi A, Judson I, Nishida T, et al. Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). Eur J Cancer 2009; 45:1103-1106.
    • (2009) Eur J Cancer , vol.45 , pp. 1103-1106
    • Gronchi, A.1    Judson, I.2    Nishida, T.3
  • 37
    • 33749459756 scopus 로고    scopus 로고
    • Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis
    • Miettinen M, LasotaJ. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130:1466-1478.
    • (2006) Arch Pathol Lab Med , vol.130 , pp. 1466-1478
    • Miettinen, M.1    Lasota, J.2
  • 38
    • 71449088757 scopus 로고    scopus 로고
    • Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: A retrospective analysis
    • Gold JS, Gonen M, Gutierrez A, et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 2009; 10:1045-1052.
    • (2009) Lancet Oncol , vol.10 , pp. 1045-1052
    • Gold, J.S.1    Gonen, M.2    Gutierrez, A.3
  • 39
    • 73949137372 scopus 로고    scopus 로고
    • Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: Comparison of DHPLC and DNA sequencing methods using a single population-based cohort
    • Battochio A, Mohammed S, Winthrop D, et al. Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: comparison of DHPLC and DNA sequencing methods using a single population-based cohort. Am J Clin Pathol 133: 149-155.
    • Am J Clin Pathol , vol.133 , pp. 149-155
    • Battochio, A.1    Mohammed, S.2    Winthrop, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.